H.R. 1266 · 119TH CONGRESSHouse · Jul 21, 2026
Combating Illicit Xylazine Act
Take Action
Introduced
House
Senate
Resolving Differences
President
Became Law
Description
Combating Illicit Xylazine Act
Step 2 of 6 · House
Combating Illicit Xylazine Act
Referred to the Subcommittee on Health.
Feb 12, 2025
Mar 26, 2026 · 14:00
| Name | Position | Links |
|---|---|---|
| Dr. K. Fred Gingrich II, DVM | Executive Director, American Association of Bovine Practitioners | |
| Dr. Nabarun Dasgupta, PhD, MPH | Senior Scientist and Gillings Innovation Fellow, University of North Carolina at Chapel Hill | |
| Dr. Yngvild Olsen, MD, MPH | Former Director of the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, and National Advisor, Manatt H | |
| Mr. Dennis Lemma | Sheriff, Seminole County, Florida, and Former President of the Major County Sheriffs of America | |
| Mr. Scott Oulton | President, INTR3PID Solutions LLC |
Subcommittee Consideration and Mark-up Session Held
Jun 25, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
Jun 25, 2026
Jun 25, 2026 · 13:00
Jul 1, 2026 · 11:00
Committee Consideration and Mark-up Session Held
Jul 20, 2026
Jul 20, 2026 · 17:00
Committee Consideration and Mark-up Session Held
Jul 21, 2026
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
Jul 21, 2026